ArticleACS infectious diseases2021

Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from

Michiyoshi Nukaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.